Hi-Tech pipes has mammoth growth prospects in the structural steel tubes space given its (a) Capacity expansion from 0.58 MTPA in FY23, 0.75 MTPA in FY24 to 1 MTPA in FY25E, (b) Transition from generic products to value-added products, (c) Product portfolio enhancement on back of Solar torque tubes, color coated roofing sheets and (d) Healthy demand for structural steel tube over medium and long term (Budgeted Allocation for Jal Jeevan Mission of Rs 70,163 cr in Budget 24-25)
In the analyst meet, PWGR management highlighted a total capex potential of INR6.6t in Inter-State Transmission Systems, where PWGR holds a leading 50-60% market share. Management also highlighted six upcoming HVDC projects and three cross-border linkage projects (India-Bangladesh, India Myanmar, and India-Sri Lanka), in which PWGR remains well placed to compete and execute
Grauer and Weil (G&W) enjoys a strong moat in its core Electroplating Chemicals business around: the recipe of the chemicals (IP), customising the product to the requirements of the customer and providing customer service through Pan-India technical centres. Consequently, there are strong entry barriers/barriers to scale in the industry with G&W and Artek being the only 2 large Indian companies alongside a few MNC players. Moreover, G&W has created strong competitive edge through backward integration into engineering electroplating equipments as well to the in-house manufacturing of certain intermediates
Avalon Technologies (AVALON) reported a strong quarter, with revenue growing 37% YoY in 2QFY25, led by a healthy recovery in US operations (up 57% YoY) and consistent performance in the Indian business (up 16% YoY). Operating profitability improved (up 470bp) led by a shift in ~45- 50% of the US manufacturing operations to India and favorable operating leverage
Yatharth Hospitals reported a healthy revenue growth which was marginally below our estimates, while EBITDA was slightly below our expectations due to increased employee cost on recruiting leading doctors in the NCR region during Q2FY25
JBCP is well-positioned to capitalize on immediate growth opportunities. We expect 29% EPS CAGR over FY24-26E aided by 1) Strong growth from domestic business (CAGR of 15% FY24-FY27E), 2) ~30% growth over FY24-FY26E from acquired portfolios, 3) scaling up of high margin CDMO business on the back of new therapy launches and 4) robust FCF generation. We maintain our Buy rating on the stock with similar target price to Rs 2,217, valuing the company at 36x Sept’26E EPS
APTUS reported a healthy quarter led by pick up in disbursements, steady spreads and asset quality. Management remained confident of maintaining strong AUM growth and stable asset quality in FY25. APTUS’s core strengths and prudent underwriting practice provide comfort. At CMP the stock is trading at 3.4x FY26 BV with RoA/ RoE of 7%/ 21%. We maintain our BUY rating on the stock with an unchanged target price of Rs. 425, valuing the company at 4.2x FY26E book value.
PCBL Ltd (erstwhile Phillips Carbon Black) is the leading manufacturer of carbon black, which is used as a reinforcing material in tyres
The Axis Top Picks Basket delivered a return of 11.6% in the last six months against the 7.5% returns posted by Nifty 50 over the same period. Amidst a highly volatile month of Oct’24 that witnessed notably mixed performance across sectors, market caps, and style indices, the Axis Top Picks basket declined by 4.4% in Oct’24 (Till 1st Nov’24 closing) but managed to beat the market performance as the benchmark Nifty 50 declined by 5.8% over the same period.
Started by renowned orthopaedic surgeon Dr Vikram Shah, Shalby is a multi-specialty hospitals chain with expertise in joint replacement.
Recent Comments